Buy or sell Bigfoot Biomedical stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Bigfoot Biomedical Stock

Type 1 diabetes management system

Founded

2014

Notable Investors

Senvest Capital

Headquarters

Milpitas CA, US

Total Funding

$92.5M

About Bigfoot Biomedical Stock

Developing an end-to-end Type 1 Diabetes Management System using simple design, cloud connectivity and human centered automation. We envision a world where the burden of T1D has largely disappeared. Rather than an omnipresent, dangerous, expensive, chronic disease, T1D is a quiet presence requiring occasional attention. All the energy that previously went into managing T1D is spent on a life well lived

Investors

Abbott Biotech Ventures

Bigfoot Biomedical

Cormorant Asset Management

Bigfoot Biomedical

Janus Capital Group

Bigfoot Biomedical

JDRF T1D Fund

Bigfoot Biomedical

Quadrant Capital Advisors

Bigfoot Biomedical

Senvest Capital

Spotify, Bigfoot Biomedical

Visionnaire Ventures

Bigfoot Biomedical, Helpshift

Funding History

November 2014$2.0M
October 2016$35.5M
December 2017$37.0M
March 2018$18.0M

Management

Co-Founder & Chief Executive Officer

Brewer Jeffrey

Chief Financial Officer

Brett Hale

Chief Technology Officer

Ian Hanson

Chief Commercial Officer

Jyoti Palaniappan

Press

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Bigfoot Biomedical or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 70K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo